RECURRENT PREGNANCY LOSS Rukset Attar, MD, PhD Obstetrics and Gynecology Department.

Slides:



Advertisements
Similar presentations
The Diagnostic Evaluation and Treatment of Recurrent Pregnancy Loss
Advertisements

Venous Thrombo-embolism In Pregnancy
RECURRENT PREGNANCY LOSS. 1. Anatomic 2. Infectious 3. Endocrine 4. Immunologic 5. Genetic 6. Male factor 7. Environment al _________.
Dr Muhabat Salih Saeid MRCOG- London-UK
Genital Herpes Prevention and Clinical Services: What Should Health Departments Do Now? H. Hunter Handsfield, M.D. University of Washington Public Health.
Unique Challenges in MPNs 2012 Bay Area MPN Patient Symposium Laura C. Michaelis, MD Loyola University Medical Center.
Care of the pregnant woman Year 2 Lent term. The Case 38 year old booked at 12 weeks gestation in the antenatal clinic Expecting her third baby 1 st baby.
Management of Stillbirth Christopher R. Graber, MD Salina Women’s Clinic 27 Jan 2012.
Fawaz Edris MD, RDMS, FRCSC, FACOG, AAACS
Non-molar triploidy followed by triploid molar pregnancy in a patient with recurrent miscarriage Introduction Recurrent miscarriage, defined as loss of.
1 Classification criteria for APS Clinical Criteria (Sydney 2004) Myakis et al. J Thromb Haemost 2006;4: Vascular thrombosis one or more clinical.
Bleeding in early pregnancy Dr. Abdalla H. Alsadig MD.
Bleeding causes in the first trimester pregnancy
Recurrent Miscarriage, Investigation and Treatment of Couples
RECURRENT AND MID- TRIMESTER PREGNANCY LOSS David L. Berry, M.D. Austin Perinatal Associates Seton Medical Center OB Grand Rounds September 19, 2011.
Anticoagulant therapy in RPL Dr. Z. Heidar Assistant professor SBMU.
Anti-phospholipid syndrome Clinton Mitchell 5th year Haematology.
This lecture was conducted during the Nephrology Unit Grand Ground by Nephrology Registrar under Nephrology Division, Department of Medicine in King Saud.
Management thrombophilia. introduction Twenty percent of maternal deaths in the United States during that period were attributed to PE. Inherited thrombophilias.
ASSOCIATE PROFESSOR IOLANDA BLIDARU
When the uterus is large or small for dates....
RECURRENT MISCARRIAGE GUIDELINES
Every year there are an estimated 200 million pregnancies in the world. Each of these pregnancies is at risk for an adverse outcome for the woman and.
Early Fetal Wastage “ Miscarriage” Professor Hassan Nasrat.
Miscarriage, Abortion and ectopic pregnancy
Abortion (miscarriage)
IDENTIFICATION AND MANAGEMENT ABORTION Prepared by: Loveness Mwase Kaweche Mwase Ackson Chandula Warwick-Etatmba.
CHLAMYDIA, RUBELLA AND CMV (ELISA). Abortion Defined as delivery occurring before the 28 th completed week of gestation Fetus weighing less than 500g.
Max Brinsmead MB BS PhD May A summary of...  RCOG Green-top Guideline number 17 April 2011  “The Investigation and Treatment of Couples with Recurrent.
Second trimester pregnancy loss
Miscarriage ( abortion Early pregnancy loss Dr. R. EL-Gantri Associated Professor Obst. & Gyne. Department.
Antiphospholipid Syndrome
Vaginal Bleeding in Early Pregnancy Dr Dalya Alhamdan Consultant Ob/ Gyn Salmaniya Medical Complex.
Chapter 7 Genetic and Developmental Diseases. Review of Structure and Function Fertilization is the uniting of a sperm and ovum resulting in 23 pairs.
Thrombophilia National Haemophilia Director
Congenital Heart Disease
Hypercoagulable States. Acquired versus inherited Acquired versus inherited “Provoked” vs idiopathic VTE “Provoked” vs idiopathic VTE Who should be tested.
Severe vascular lesions and poor functional outcome
Recurrent Pregnancy Loss An Overview
RECURRENT MISCARRIAGE & SEPTIC ABORTION DR. ROBINA TARIQ Associate PROF. OBS / GYNAE SERVICES INSTITUTE OF MEDICAL SCIENCES /
Preterm Birth Hazem Al-Mandeel, M.D Course 481 Obstetrics and Gynecology Rotation.
ABORTIONS. Definition Termination of pregnancy before the period of viability.
Preterm Labor & Preterm Birth Family Medicine Specialist CME Vientiane, Lao PDR December 10 – 12, 2008.
Abortion (miscarriage) طیبه غریبی عضو هیئت علمی دانشکده پرستاری و مامایی.
Objectives:  At the end of this lecture, the student should:  Know the main categories of bleeding in early pregnancy.  Can clinically assess a woman.
ABORTION Razieh M. Jaafari, MD Dept of ObGyn Ahwaz University of Med. Science.
RECURRENT MISCARRIAGE Dr.F Mardanian MD. CASE CASE 35 Y G5L1Ab4 G1=L1 G2=16weeks G3=8weeks G4=12weeks G5=16weeks BW=105kg 35 Y G5L1Ab4 G1=L1 G2=16weeks.
ANTIPHOSPHOLIPID SYNDROME CLINICAL MANIFESTATIONS.
HYPOTHYROIDISM. INTRODUCTION  Hypothyroidism is defined as a deficiency in thyroid hormone secretion and action that produces a variety of clinical signs.
Definition & Risk Factors of FGR FGR, also called IUGR is the term used to describe a fetus that has not reached its growth potential because of genetic.
Early pregnancy problems Dr. Mohamed Khalil MD, MRCOG. Diploma in Fetal Medicine RCOG/RCR Consultant Obst & Gyn Security Forces Hospital.
Recurrent Miscarriage Guidelines Recurrent Miscarriage Guidelines Dr Muhammad El Hennawy Ob/gyn specialist Rass el barr central hospital and dumyat specialised.
The antiphospholipid syndrome (APS) is defined by two major components (see 'Classification criteria' below: 'Classification criteria' The occurrence.
LABORATORY APPROACH TO SUBFERTILITY AND MISCARRIAGES
Recurrent Pregnancy Loss The case for a Dedicated Specialist Clinic.
Recurrent pregnancy loss
2nd trimester Miscarraige
Fetal Demise
Pregnancy in women with antiphospholipid syndrome
Immunological disorder during pregnancy
Recurrent Miscarriage
Antiphospholipid Antibody Syndrome
Immunology of Recurrent Pregnancy Loss
Recurrent Pregnancy Loss
Autoimmune disease in pregnancy
Dr Ferdous Mehrabian. Dr Ferdous Mehrabian Inherited thrombophilias in pregnancy Inherited thrombophilias is a genetic tendency to venous thrombosis.
نازایی و سقط مکرر F.Jahanshad MD NAVID’S INSTITUTE OF INFERTILITY
Fetal loss Infectious causes , Autopsy findings
The USC Stillbirth Experience
Presentation transcript:

RECURRENT PREGNANCY LOSS Rukset Attar, MD, PhD Obstetrics and Gynecology Department

Early pregnancy loss is defined as Early pregnancy loss is defined as the termination of pregnancy before 20 weeks' gestation or the termination of pregnancy before 20 weeks' gestation or with a fetal weight of <500 g with a fetal weight of <500 g Most investigators agree that both ectopic and molar pregnancies should not be included in the definition Most investigators agree that both ectopic and molar pregnancies should not be included in the definition

Terms Used to Describe Pregnancy Loss Chemical pregnancy loss Loss of a biochemically evident pregnancy Early pregnancy loss Abortion of the first trimester, loss of a histologically recognized pregnancy, or a loss based on ultrasonographic findings Spontaneous abortions (SAB) Pregnancy loss before 20 weeks' gestation, as based on last menstrual period

Terms Used to Describe Pregnancy Loss Habitual or recurrent abortion 2 or more consecutive SABs Stillbirth Pregnancy loss after 20 weeks' gestation (Neonatal loss is the death of a liveborn fetus.)

Incidence 10-15% true rate of early pregnancy loss is close to 50% because of the high number of chemical pregnancies that are not recognized in the 2-4 weeks after conception

Etiology The most common causes of recurrent miscarriages are as follows: Genetic causes Aneuploidy Somatic Sex chromosome Mendelian disorders Multifactorial disorders Parental chromosomal abnormalities (translocations) Chromosomal inversions

Etiology Immunologic causes Autoimmune causes Alloimmune causes Anatomic causes Uterine Müllerian anomalies Uterine septum (the anomaly most commonly associated with pregnancy loss) Hemiuterus (unicornuate uterus) Bicornuate uterus

Etiology Diethylstilbestrol-linked condition Diethylstilbestrol-linked condition Acquired defects (eg, Asherman syndrome) Acquired defects (eg, Asherman syndrome) Incompetent cervix Incompetent cervix Leiomyomas Leiomyomas Uterine polyps Uterine polyps

Etiology Infectious causes Environmental causes (Smoking, excessive alcohol consumption, caffeine) Endocrine factors (Diabetes mellitus, Antithyroid antibodies, Luteal phase deficiency)Luteal phase deficiency Hematologic disorder

Etiology The gestational age at the time of the SAB can provide clues about the cause The gestational age at the time of the SAB can provide clues about the cause nearly 70% of SABs in the first 12 weeks are due to chromosomal anomalies nearly 70% of SABs in the first 12 weeks are due to chromosomal anomalies losses due to antiphospholipid syndrome (APS) and cervical incompetence tend to occur after the first trimester. losses due to antiphospholipid syndrome (APS) and cervical incompetence tend to occur after the first trimester.

Immunological Factors Autoimmune factors include various autoantibodies such as Autoimmune factors include various autoantibodies such as anti-phospholipid antibodies (APA) anti-phospholipid antibodies (APA) antinuclear antibodies (ANA) antinuclear antibodies (ANA) anti-thyroid antibodies (ATA) anti-thyroid antibodies (ATA) Antiphospholipid antibodies (APA) are antibodies directed against negatively charged phospholipid molecules constituting parts of the membranes of the cell surfaces and cell organelles Antiphospholipid antibodies (APA) are antibodies directed against negatively charged phospholipid molecules constituting parts of the membranes of the cell surfaces and cell organelles Almost all of the fetal demises in women with SLE are related to APAs. Almost all of the fetal demises in women with SLE are related to APAs.

Antiphospholipid Syndrome was originally defined as the association between antiphospholipid antibodies and either recurrent miscarriage, thrombosis, or thrombocytopenia was originally defined as the association between antiphospholipid antibodies and either recurrent miscarriage, thrombosis, or thrombocytopenia is the most important treatable cause of recurrent miscarriage is the most important treatable cause of recurrent miscarriage Anti phospholipid antibodies are a family of about 20 anti bodies that are directed against phospholipid binding plasma proteins. Anti phospholipid antibodies are a family of about 20 anti bodies that are directed against phospholipid binding plasma proteins. The common antiphospholipid antibodies The common antiphospholipid antibodies (APAs) lupus anticoagulant (LAC) (APAs) lupus anticoagulant (LAC) anticardiolipin (ACA) anticardiolipin (ACA) anti-b2 glycoprotein I (b2GPI) anti-b2 glycoprotein I (b2GPI) antiannexin V antiannexin V

Antiphospholipid Syndrome Clinical features Clinical features venous or arterial thrombosis, venous or arterial thrombosis, unexplained fetal deaths after 10 weeks, unexplained fetal deaths after 10 weeks, delivery at or before 34 weeks as a result of severe pregnancy-induced hypertension (PIH) or delivery at or before 34 weeks as a result of severe pregnancy-induced hypertension (PIH) or recurrent pregnancy loss (RPL) before 10 weeks recurrent pregnancy loss (RPL) before 10 weeks One of the clinical features in combination with a positive laboratory result of antibodies to cardiolipin (CL) or a positive lupus anticoagulant (LAC) on two occasions at least 6 (12) weeks apart are parameters for diagnosis of the antiphospholipid antibody syndrome (APS) (Wilson et al., 2001). One of the clinical features in combination with a positive laboratory result of antibodies to cardiolipin (CL) or a positive lupus anticoagulant (LAC) on two occasions at least 6 (12) weeks apart are parameters for diagnosis of the antiphospholipid antibody syndrome (APS) (Wilson et al., 2001).

Treatment options include the following: Treatment options include the following: Subcutaneous heparin Subcutaneous heparin Low-dose aspirin Low-dose aspirin Prednisone Prednisone Immunoglobulins Immunoglobulins Combinations of these therapies Combinations of these therapies Several well-controlled studies showed that subcutaneous heparin (5000 U) given twice a day with low-dose aspirin 81 mg/d increases fetal survival rates from 50% to 80% among women who have had at least 2 losses and who have unequivocally positive results for APLA. Several well-controlled studies showed that subcutaneous heparin (5000 U) given twice a day with low-dose aspirin 81 mg/d increases fetal survival rates from 50% to 80% among women who have had at least 2 losses and who have unequivocally positive results for APLA.

Infectious Causes infection is viewed as a rare cause of recurrent miscarriage. infection is viewed as a rare cause of recurrent miscarriage. A recent review failed to show sufficient evidence for the notion that any type of infection can be identified as a causal factor for recurrent miscarriage. A recent review failed to show sufficient evidence for the notion that any type of infection can be identified as a causal factor for recurrent miscarriage. Most patients with a history of recurrent miscarriage do not benefit from an extensive infection workup Most patients with a history of recurrent miscarriage do not benefit from an extensive infection workup

Infectious Causes Listeria Monocytogenes Listeria Monocytogenes Listeria Monocytogenes Listeria Monocytogenes Chlamydial Genitourinary Infections Chlamydial Genitourinary Infections Chlamydial Genitourinary Infections Chlamydial Genitourinary Infections Ureaplasma Infection Ureaplasma Infection Ureaplasma Infection Ureaplasma Infection Mycoplasma Infections Mycoplasma Infections Mycoplasma Infections Mycoplasma Infections Bacterial Vaginosis Bacterial Vaginosis Bacterial Vaginosis Bacterial Vaginosis Cytomegalovirus Cytomegalovirus Cytomegalovirus Rubella Rubella Rubella Herpes Simplex Herpes Simplex Herpes Simplex Herpes Simplex HIV Disease HIV Disease HIV Disease HIV Disease Parvovirus B19 Infection Parvovirus B19 Infection Parvovirus B19 Infection Parvovirus B19 Infection Toxoplasmosis Toxoplasmosis Toxoplasmosis Treponematosis (Endemic Syphilis) Treponematosis (Endemic Syphilis) Treponematosis (Endemic Syphilis) Treponematosis (Endemic Syphilis) Lyme Disease Lyme Disease Lyme Disease Lyme Disease Malaria Malaria Malaria

Summary Genetic causes Genetic causes Perform karyotype of parents with family or personal history of genetic abnormalities. Perform karyotype of parents with family or personal history of genetic abnormalities. Perform karyotype of the abortus in recurrent cases. Perform karyotype of the abortus in recurrent cases. Provide genetic counseling for families with recurrent loss or familial history of genetic disease. Provide genetic counseling for families with recurrent loss or familial history of genetic disease. In patients with a high risk for recurrent, chromosomally abnormal conceptus, discuss the options of adoption, gamete donation, and PGD. In patients with a high risk for recurrent, chromosomally abnormal conceptus, discuss the options of adoption, gamete donation, and PGD. Immunologic causes Immunologic causes Perform APLA testing if indicated. Perform APLA testing if indicated. If APLA levels are elevated, counseling with a hematologist and a specialist in maternal fetal medicine is recommended. If APLA levels are elevated, counseling with a hematologist and a specialist in maternal fetal medicine is recommended. Aspirin and heparin therapy may be given to patients who are diagnosed with APS. Aspirin and heparin therapy may be given to patients who are diagnosed with APS.

Anatomic causes Anatomic causes Imaging may include HSG, hysteroscopy, ultrasonography, and/or MRI. Imaging may include HSG, hysteroscopy, ultrasonography, and/or MRI. Surgical correction may be required. Surgical correction may be required. Infectious causes Infectious causes Cervical cultures should be obtained during the evaluation of infertility. Cervical cultures should be obtained during the evaluation of infertility. Empiric antibiotics should be given before invasive testing, such as HSG. Empiric antibiotics should be given before invasive testing, such as HSG. Environmental causes - Encourage life-style changes and counseling for preventable exposures. Environmental causes - Encourage life-style changes and counseling for preventable exposures. Endocrine factors - Perform thyroid-stimulating hormone (TSH) screening in symptomatic patients. Endocrine factors - Perform thyroid-stimulating hormone (TSH) screening in symptomatic patients. Thrombophilic disorders - Aspirin and heparin therapy may be given for proven diagnoses. Thrombophilic disorders - Aspirin and heparin therapy may be given for proven diagnoses.